U90926 inhibitors are a class of chemical compounds designed to inhibit the activity of the U90926 enzyme or protein, which plays a critical role in specific biochemical pathways. These inhibitors are highly specialized molecules that interact with the active or allosteric sites of the U90926 protein, preventing its normal function. The U90926 protein is often associated with enzymatic catalysis, molecular signaling, or structural roles in cells, making its inhibition a valuable target for studying the effects of modulating its biological activity. U90926 inhibitors are typically developed through methods such as rational drug design, where the three-dimensional structure of the protein is analyzed to identify key binding sites, or through high-throughput screening, which tests large libraries of compounds for inhibitory activity. These inhibitors can vary greatly in terms of their chemical structures, from small organic molecules to larger, more complex synthetic compounds, each designed to optimize binding affinity and specificity toward the U90926 protein.
In terms of their molecular mechanics, U90926 inhibitors can act in a competitive, non-competitive, or uncompetitive manner. Competitive inhibitors bind directly to the enzyme's active site, competing with the natural substrate for access, while non-competitive inhibitors typically bind at allosteric sites, inducing conformational changes that reduce enzymatic activity. Uncompetitive inhibitors, on the other hand, bind only to the enzyme-substrate complex, further reducing catalytic efficiency. The binding interactions of U90926 inhibitors are often characterized by their kinetic parameters, such as the dissociation constant (K_i) or inhibition constant (IC50), which quantify the inhibitor's potency. Studying these inhibitors helps to uncover the specific role of the U90926 protein in broader biochemical pathways and systems, providing insights into molecular interactions, protein dynamics, and enzyme regulation at the cellular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits the expression of cDNA sequence U90926 by intercalating into DNA, preventing transcription initiation and elongation, thereby blocking the synthesis of mRNA. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin inhibits the expression of cDNA sequence U90926 by binding to RNA polymerase II, preventing RNA synthesis, and transcriptional elongation, resulting in reduced mRNA levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin inhibits the expression of cDNA sequence U90926 by binding to bacterial RNA polymerase, blocking the initiation of transcription, which indirectly affects mRNA synthesis. | ||||||
Thiolutin | 87-11-6 | sc-200387 sc-200387A | 1 mg 5 mg | $99.00 $398.00 | 1 | |
Thiolutin inhibits the expression of cDNA sequence U90926 by binding to RNA polymerase, preventing its activity, and blocking the synthesis of mRNA, thereby reducing gene expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin inhibits the expression of cDNA sequence U90926 by being incorporated into mRNA during transcription, leading to premature termination of transcription and reduced mRNA levels. | ||||||
Siomycin A | 12656-09-6 | sc-202339 sc-202339-CW sc-202339A sc-202339B | 500 µg 500 µg 2.5 mg 25 mg | $439.00 $449.00 $1326.00 $10200.00 | 4 | |
Siomycin A inhibits the expression of cDNA sequence U90926 by binding to RNA polymerase and preventing the formation of the transcription complex, thus halting transcription elongation. | ||||||